Hims & Hers Health Inc (NYSE:HIMS)
$ 21.435 0.675 (3.25%) Market Cap: 4.64 Bil Enterprise Value: 4.42 Bil PE Ratio: 267.94 PB Ratio: 12.84 GF Score: 54/100

Hims & Hers Health Inc at Citi Healthcare & Medtech Conference Transcript

Mar 02, 2023 / 03:15PM GMT
Release Date Price: $10.35 (-10.23%)
Daniel R. Grosslight
Citigroup Inc., Research Division - Research Analyst

All right. We'll get started. Thank you all for joining us for the Hims & Hers fireside chat. My name is Daniel Grosslight, I'm the health care technology analyst here at Citi. And I'm very pleased to welcome the CFO of Hims & Hers, Yemi -- I don't want to butcher this, Okupe. Thanks for joining us this afternoon.

Yemi Okupe
Hims & Hers Health, Inc. - CFO

Thanks, appreciate it.

Questions & Answers

Daniel R. Grosslight
Citigroup Inc., Research Division - Research Analyst

So let's start off with the quarter you just announced on Monday, a very impressive beat and raise. It seems like in a world where there's been some disappointing earnings from telehealth companies, you've kind of stood out from the pack with continued beats and raises throughout the last year.

And just to recap for folks in the room who might not be familiar, you introduced guidance that implies around 40% top line growth and your EBITDA is

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot